Evotec SE (EVOTF) Shares Outstanding (Diluted Average) (2020 - 2021)
Evotec SE's (EVOTF) quarterly Shares Outstanding (Diluted Average) came in at $1768.9 in Q3 2021, up 3685.99% year-on-year from $46.72 in Q3 2020, and down 97.87% quarter-over-quarter from $83094.7 in Q2 2021.
Evotec SE (EVOTF) Shares Outstanding (Diluted Average) (2020 - 2021) Analysis & Trends
Evotec SE has disclosed Shares Outstanding (Diluted Average) across 2 years of filings, most recently posting $1768.9 for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 1,768.93 |
| Jun 30, 2021 | 83,094.73 |
| Sep 30, 2020 | 46.72 |